170 related articles for article (PubMed ID: 22917269)
1. Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth.
Liu JR; Sheng XY; Hu YQ; Yu XG; Westcott JE; Miller LV; Krebs NF; Hambidge KM
BMC Pediatr; 2012 Aug; 12():129. PubMed ID: 22917269
[TBL] [Abstract][Full Text] [Related]
2. Fecal Calprotectin in Healthy Children Aged 1-4 Years.
Zhu Q; Li F; Wang J; Shen L; Sheng X
PLoS One; 2016; 11(3):e0150725. PubMed ID: 26950440
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin concentrations in healthy children aged 1-18 months.
Li F; Ma J; Geng S; Wang J; Liu J; Zhang J; Sheng X
PLoS One; 2015; 10(3):e0119574. PubMed ID: 25742018
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin level in healthy children aged less than 4 years in South Korea.
Song JY; Lee YM; Choi YJ; Jeong SJ
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28092115
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Fecal Calprotectin in Preterm Infants with Necrotizing Enterocolitis.
Zhang M; Zhang X; Zhang J
Clin Lab; 2016; 62(5):863-9. PubMed ID: 27349012
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the different kinds of feeding on the level of fecal calprotectin.
Li F; Ma J; Geng S; Wang J; Ren F; Sheng X
Early Hum Dev; 2014 Sep; 90(9):471-5. PubMed ID: 25025530
[TBL] [Abstract][Full Text] [Related]
7. Delivery and feeding mode affects fecal calprotectin levels in infants <7months old.
Lee YM; Min CY; Choi YJ; Jeong SJ
Early Hum Dev; 2017 May; 108():45-48. PubMed ID: 28391117
[TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey.
Hestvik E; Tumwine JK; Tylleskar T; Grahnquist L; Ndeezi G; Kaddu-Mulindwa DH; Aksnes L; Olafsdottir E
BMC Pediatr; 2011 Feb; 11():9. PubMed ID: 21284894
[TBL] [Abstract][Full Text] [Related]
9. [Fecal calprotectin levels in preterm infants during the early neonatal period].
Cui X; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):165-8. PubMed ID: 22433399
[TBL] [Abstract][Full Text] [Related]
10. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years.
Ellemunter H; Engelhardt A; Schüller K; Steinkamp G
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):438-442. PubMed ID: 28207476
[TBL] [Abstract][Full Text] [Related]
11. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life.
Yang Q; Smith PB; Goldberg RN; Cotten CM
Neonatology; 2008; 94(4):267-71. PubMed ID: 18784422
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases.
Inoue K; Aomatsu T; Yoden A; Okuhira T; Kaji E; Tamai H
J Gastroenterol Hepatol; 2014; 29(7):1406-12. PubMed ID: 24635100
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease.
Aomatsu T; Yoden A; Matsumoto K; Kimura E; Inoue K; Andoh A; Tamai H
Dig Dis Sci; 2011 Aug; 56(8):2372-7. PubMed ID: 21394462
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children.
Teng X; Gao C; Sun M; Wu J
Clin Rheumatol; 2018 Jun; 37(6):1667-1673. PubMed ID: 29018973
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin in healthy children.
Oord T; Hornung N
Scand J Clin Lab Invest; 2014 Apr; 74(3):254-8. PubMed ID: 24568692
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study.
Ye L; Chen BQ; Wang SD; Shi H; Yang Z; Wang FY
Scand J Gastroenterol; 2017 Oct; 52(10):1113-1119. PubMed ID: 28675068
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin in systemic sclerosis and review of the literature.
Marie I; Leroi AM; Menard JF; Levesque H; Quillard M; Ducrotte P
Autoimmun Rev; 2015 Jun; 14(6):547-54. PubMed ID: 25661980
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin as a promising marker of inflammatory diseases.
Paduchova Z; Durackova Z
Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
